Navigation Links
Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting
Date:5/21/2009

REDWOOD CITY, Calif., May 21 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from three studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2, 2009, at the Orange County Convention Center in Orlando, Florida. The company currently markets the widely-adopted Oncotype DX(R) breast cancer test, which is clinically validated to predict the likelihood of recurrence and chemotherapy benefit in early-stage breast cancer patients, and plans to launch a test for colon cancer in early 2010 based on positive results from the QUASAR validation study being presented at ASCO.

    Presentation details are as follows:

    Colon Cancer
        -- Saturday, May 30, 2009, 3 p.m. ET
           Abstract # 4000
           Oral presentation: "A quantitative multi-gene RT-PCR assay for
           prediction of recurrence in stage II colon cancer:  Selection of
           the genes in 4 large studies and results of the independent,
           prospectively-designed QUASAR validation study" Presenter: David
           Kerr, M.D., DSc, professor of cancer medicine at the University of
           Oxford Location: Level 2, West Hall D2

    In addition, an archived webcast of the advance presscast highlighting the
    QUASAR colon cancer validation study is available on ASCO's Web site at
    www.asco.org.

    Breast Cancer
        -- Sunday, May 31, 2009, 4:30 p.m. ET
           Abstract # 500
           Oral presentation: "Genotypic characterization of phenotypically
           defined triple-negative breast cancer"
           Presenter: Joseph A. Sparano, M.D., professor of medicine and
           women's health at Albert Einstein College of Medicine and director
           of the Breast Evaluation Center of Montefiore-Ei
'/>"/>
SOURCE Genomic Health
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
4. Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference
5. Genomic profiling of lung tumors helps doctors choose most effective treatment
6. Genomic technologies to identify toxic chemicals should be developed
7. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
8. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Genomic Health to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... (PRWEB) May 27, 2015 This year, ... health awareness campaign and encouraging those affected to seek assistance ... Mental Health (NAMI), one in five children, ages 13 ... illness. Additionally, 50% of all cases of mental illness within ... suggesting, it is essential to seek help before reaching a ...
(Date:5/27/2015)... One of America's most cherished actors, James Earl ... that takes a look at the topic of atrial ... abnormal heart rhythm. Those who suffer from atrial fibrillation ... too quickly. , This new segment will take a ... to inform viewers about possible signs that commonly indicate ...
(Date:5/27/2015)... Long Island, New York (PRWEB) May 27, 2015 ... Wellness Day Spa will now be offering Eco-fin ... 2015. The Eco-fin treatment is a paraffin wax alternative. ... is made with 100% natural plant-based emollients and pure ... are used. , "We have used Eco-fin treatments for ...
(Date:5/27/2015)... The Advanced Fertility Center of Chicago announces that their ... better serve the needs of couples in Chicagoland. The ... Northwest side of the city at 4920 North Central Ave., ... the Chicago office at (773) 794–1818. This is the ... The other 2 offices are in Gurnee and Crystal ...
(Date:5/26/2015)... May 27, 2015 Local dentist Abid ... more restful night’s sleep. Dr. Paghdiwala of Pearl Dental ... Medicine (AADSM) member. AADSM is the leading national organization ... with oral appliance therapy, an effective alternative treatment to ... , “Sleeping with a CPAP machine, which ...
Breaking Medicine News(10 mins):Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3Health News:Long Island's Massage and Spa Of Commack Announces A Change To Their Spa Party Menu Of Services 2Health News:Long Island's Massage and Spa Of Commack Announces A Change To Their Spa Party Menu Of Services 3Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Philadelphia sleep apnea dentist now offers oral appliances to treat snoring 2
... value has been attached to the high cost of pain ... a massive annual cost of $34.3 billion -- nearly $11,000 ... pain. The price tag of pain includes both financial ... study The High Price of Pain: The Economic Impact of ...
... 90% of people miss out on critical early treatment period, ... call them transient ischemic attacks, but they,re more commonly known ... be deadly. , What,s worse, many people who suffer such ... people who experienced symptoms of a transient ischemic attack (TIA) ...
... Holdings, Inc. ("IHHI") (OTC Bulliten Board: IHCH), the ... its financial,results for the second quarter ended September ... reported consolidated net operating revenues of $95.4 million ... increase of $10.1 million, or,11.8%, from the comparable ...
... Drug Costs for America,s Seniors, WASHINGTON, Nov. ... of Inspector General (OIG) finding that in Medicare ... the time when generic,substitutes were available and that ... that proven pharmacy benefit manager (PBM) tools are,driving ...
... - ZYRTEC(R) and ZYRTEC-D(R) 12 HOUR(R) to be Available in Stores ... ... FT. WASHINGTON, Pa., Nov. 16 McNeil Consumer,Healthcare, a division of ... and Drug Administration (FDA) for the,allergy treatment ZYRTEC(R) (cetirizine HCl) to ...
... Nov. 16 The National Football,League Alliance Partnership ... heart health screenings for former NFL players. ... Medical Center.,Partnering with Dr. Jeffrey Boone, founder of ... medical experts and a 64-slice CT scanner.,More than ...
Cached Medicine News:Health News:First study of Australia's high cost of pain reveals $34 billion price tag 2Health News:Mini Strokes: Major Health Threats 2Health News:Mini Strokes: Major Health Threats 3Health News:IHHI Announces Second Quarter Earnings 2Health News:IHHI Announces Second Quarter Earnings 3Health News:New OIG Report Confirms Part D Plans Are Driving Generic Utilization 2Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 2Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 3Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 4Health News:Broward Health and ProHeart MD Kick Off NFL Alumni Health Program 2
(Date:5/27/2015)... , May 27, 2015  BioDelivery Sciences International, Inc. (NASDAQ: ... and Chief Executive Officer of BDSI, will present at two important ... Conference Tuesday, June 2 8:30 AM Eastern Time Grand Hyatt, ... William Blair 35 th Annual Growth Stock Conference Tuesday, ... Seasons Hotel, Chicago, IL , ...
(Date:5/27/2015)... Biomedical Catalyst Award to ... Cancer  Crescendo Biologics Limited (Crescendo) today ... (ADC) programme with the support of a Biomedical ... UK. This feasibility award will enable the validation ... novel product format based on Crescendo,s Humabody™ antibody ...
(Date:5/26/2015)... 2015  AbbVie (NYSE: ABBV ) presented ... of its investigational, all-oral, interferon (IFN)- and ribavirin ... the Annual Meeting of the Japan Society of ... 1 GIFT-I evaluated genotype 1b (GT1b) chronic ... and without cirrhosis, who were either treatment-naïve or ...
Breaking Medicine Technology:BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 3Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6
... Stryker Corporation (NYSE: SYK ) today announced that the U.S. ... undertaken to address issues raised in two Warning Letters received in 2007 ... , , ... certain quality system requirements at its reconstructive implant manufacturing facility in ...
... China , May 19 /PRNewswire-Asia-FirstCall/ -- ... the "Company"),(OTC Bulletin Board: CRUI), a manufacturer and distributor ... pharmaceuticals, construction materials,PVC products, foods and beverages and cosmetics, ... March 31, 2010 . , , ...
Cached Medicine Technology:Stryker Announces Resolution of Two FDA Warning Letters 2China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 2China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 3China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 4China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 5China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 6China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 7China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 8China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 9China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 10China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 11China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 12
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Serrated handle with 7 mm tying platform and polished finish. Teeth: 0.25 mm, 2 x 2 set at 45 degrees....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
Medicine Products: